Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jan
24
2020
BRAG Biobased Products Blog: January 24, 2019 Bergeson & Campbell, P.C.
Jul
21
2023
EPA Extends Comment Period on Proposed SNURs for 18 Chemicals Made from Plastic Waste-Based Feedstocks Bergeson & Campbell, P.C.
Apr
5
2019
New Hazardous Waste Pharmaceutical Rule Imposes New Obligations on Health Care Providers Van Ness Feldman LLP
Dec
17
2020
New Administration Could Provide Ideal Backdrop for Tribes Entering Cannabis Industry Van Ness Feldman LLP
Apr
21
2022
Insurance Coverage Considerations for Tribal Cannabis Businesses Van Ness Feldman LLP
Dec
8
2021
Tribal Cannabis Tourism and Current Status of Federal Legislation Impacting the Cannabis Industry Van Ness Feldman LLP
Aug
6
2021
Legislative Update for the Tribal Cannabis Industry Van Ness Feldman LLP
Feb
7
2022
Hydro Newsletter - Volume 9, Issue 2 Van Ness Feldman LLP
Jun
9
2020
EPA Issues Compliance Advisory Regarding Pesticide Devices Making Claims to Kill the Novel Coronavirus Van Ness Feldman LLP
May
13
2016
3-D Printing and the Regulatory Future of Home Remedies: Pharma to Table New York University School of Law
Oct
10
2016
Difficulties with Setting Level of THC Impairedness for Drivers Rosenfeld Injury Lawyers
Sep
12
2017
Court Orders Monsanto Roundup Safety Documents to be Disclosed Rosenfeld Injury Lawyers
Mar
6
2017
Xarelto Bleeding Lawsuits Mount Against Johnson & Johnson Rosenfeld Injury Lawyers
Sep
26
2023
In Starch Contrast: Australian Patent Office Makes Key Finding on Use of Trade Marks in Patent Specifications K&L Gates
May
16
2020
COVID-19: Trump Administration Takes Actions to Assist U.S. Fishing Industry K&L Gates
Aug
13
2020
340B Update: Appellate Court Upholds 340B Payment Reduction as CMS Proposes Further Reductions for 2021 [Podcast] K&L Gates
Mar
5
2024
Highlights from FDA Regulatory Developments in Clinical Trials: 2023 Recap and 2024 Forecast [Podcast] K&L Gates
Apr
4
2017
Markush Madness: Watson Avoids Infringement by Adding an Element to a Formulation K&L Gates
Mar
19
2021
340B Drug Pricing Program 2021 Outlook [PODCAST] K&L Gates
Aug
31
2022
Cadbury’s Purple Reign: High Court Allows Cadbury to Register Their Iconic Purple Colouring K&L Gates
Aug
8
2019
Working Wise - Volume 1 K&L Gates
Nov
1
2019
Chancery Court Allows Claims Due To Manager’s Allegiance To Particular Equity Holders Over The Company K&L Gates
Mar
28
2023
Technical Effect Embodied In Technical Teaching K&L Gates
Jan
11
2017
2016-2017 Technical Review of Australian Gene Technology Regulations 2001 K&L Gates
May
26
2021
340B Update: HRSA Issues Final Warning Letter to Pharmaceutical Manufacturers that Their Contract Pharmacy Actions Violate 340B Statute K&L Gates
Mar
26
2018
Board’s Failure to Adhere to Best Practices in Drug Clinical Trial Does Not Excuse Stockholder Demand as Futile K&L Gates
Aug
26
2022
No (More) Bites at the mRNA Apple: Pfizer and BioNTech Seek Declaratory Judgment of Noninfringement Relating to Their COVID-19 Vaccine in New Suit K&L Gates
Aug
31
2022
All Federal Research Agencies to Update Public Access Policies K&L Gates
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins